Comparison of the acute effects of three structurally different converting enzyme inhibitors (captopril, SA-446 and MK-421) on blood pressure, the renin-angiotensin system and the kallikrein-kinin system.
Kondo
K
K
Kida
O
O
Kodama
K
K
Higa
T
T
Someya
N
N
Morotomi
Y
Y
Tanaka
K
K
D015097:3-Mercaptopropionic Acid / Q000031:analogs & derivatives / Q000627:therapeutic use*; D000328:Adult; D000368:Aged; D000806:Angiotensin-Converting Enzyme Inhibitors; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D001794:Blood Pressure / Q000187:drug effects; D002216:Captopril / Q000627:therapeutic use*; D004151:Dipeptides / Q000627:therapeutic use*; D004656:Enalapril; D005260:Female; D006801:Humans; D007610:Kallikreins / Q000097:blood; D007705:Kinins / Q000097:blood; D008297:Male; D008875:Middle Aged; D009842:Oligopeptides / Q000627:therapeutic use*; D011392:Proline / Q000031:analogs & derivatives*; D012084:Renin-Angiotensin System / Q000187:drug effects; D013438:Sulfhydryl Compounds; D013722:Teprotide; D053778:Thiazolidines
D000806:Angiotensin-Converting Enzyme Inhibitors; D000959:Antihypertensive Agents; D004151:Dipeptides; D007705:Kinins; D009842:Oligopeptides; D013438:Sulfhydryl Compounds; D053778:Thiazolidines; D004656:Enalapril; D011392:Proline; D002216:Captopril; D015097:3-Mercaptopropionic Acid; D013722:Teprotide; C033437:rentiapril; D007610:Kallikreins